NKTR -102

2015-02-25 23:33:23

Binary Operation Guide

首页文章页文章列表博文目录

给我悄悄话

打印被阅读次数

"We were encouraged to find that the CTC sub-study confirmed the presence of several potential target-specific pharmacodynamic biomarkers, such as topoisomerase 1, in the patients enrolled in our study," saidIvan Gergel, MD, senior vice president drug development and chief medical officer of Nektar Therapeutics. "The analysis from the BEACON CTC sub-study could help us better understand which additional patient populations would benefit from NKTR-102. We expect topline results from the BEACON study to be available in the first quarter of 2015."

登录后才可评论.

NKTR -102

切换到网页版

hydrocortisone

NKTR -102

hydrocortisone (2015-02-25 23:33:23) 评论 (0)

"We were encouraged to find that the CTC sub-study confirmed the presence of several potential target-specific pharmacodynamic biomarkers, such as topoisomerase 1, in the patients enrolled in our study," saidIvan Gergel, MD, senior vice president drug development and chief medical officer of Nektar Therapeutics. "The analysis from the BEACON CTC sub-study could help us better understand which additional patient populations would benefit from NKTR-102. We expect topline results from the BEACON study to be available in the first quarter of 2015."